Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Agricultural and Environmental Medicine

• Publication date

  2012-12-31

• Fields of study

  Law, Medicine

• Identifiers
  PMID 23311820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro metabolism studies on mephedrone and analysis of forensic cases.

  2013cited by this paper
• Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats

  2012cited by this paper
• Lethal Serotonin Syndrome After Methylone and Butylone Ingestion

  2012cited by this paper
• Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse

  2012cited by this paper
• The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

  2012cited by this paper
• Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity.

  2012cited by this paper
• Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat.

  2012cited by this paper
• Recurrent acute kidney injury following bath salts intoxication.

  2012cited by this paper
• Chemical analysis of two new designer drugs: buphedrone and pentedrone.

  2012cited by this paper
• Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish internet company.

  2012cited by this paper
• Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone

  2012cited by this paper
• Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom

  2012cited by this paper
• Mass, NMR and IR spectroscopic characterization of pentedrone and pentylone and identification of their isocathinone by-products.

  2012cited by this paper
• Determining the scale of designer drugs (DD) abuse and risk to public health in Poland through an epidemiological study in adolescents.

  2012cited by this paper
• Risk of caffeine toxicity associated with the use of ‘legal highs’ (novel psychoactive substances)

  2012cited by this paper
• Interaction of mephedrone with dopamine and serotonin targets in rats.

  2012cited by this paper
• [A new designer drug: methylone related death].

  2012cited by this paper
• The untold truth about "bath salt" highs: A case series demonstrating local tissue injury.

  2012cited by this paper
• 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.

  2012cited by this paper
• Synthesis, full chemical characterisation and development of validated methods for the quantification of the components found in the evolved "legal high" NRG-2.

  2012cited by this paper
• The Toxicology of Bath Salts: A Review of Synthetic Cathinones

  2012cited by this paper
• Purity of synthetic cannabinoids sold online for recreational use.

  2012cited by this paper
• Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.

  2011cited by this paper
• Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood.

  2011cited by this paper
• Comparison of “herbal highs” composition

  2011cited by this paper
• Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.

  2011cited by this paper
• 4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse

  2011cited by this paper
• Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases.

  2011cited by this paper
• Identification and characterization of JWH-122 used as new ingredient in "Spice-like" herbal incenses.

  2011cited by this paper
• "Bath salts" intoxication.

  2011cited by this paper
• “Bath Salts” Intoxication

  2011cited by this paper
• New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland.

  2011cited by this paper
• Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States

  2011cited by this paper
• The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.

  2011cited by this paper
• Reproductive parameters are differentially altered following subchronic administration of Catha edulis F. (Khat) extract and cathinone in male rats.

  2011cited by this paper
• GHB and synthetic cathinones: clinical effects and potential consequences.

  2011cited by this paper
• Hallucinatory delirium following use of MDPV: "Bath Salts".

  2011cited by this paper
• Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry.

  2011cited by this paper
• Energy-1 (‘NRG-1’): don't believe what the newspapers say about it being legal

  2011influential reference
• Legal highs - legal aspects and legislative solutions.

  2011influential reference
• Ivory wave: the next mephedrone?

  2011cited by this paper
• Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: a new designer drug with α-pyrrolidinophenone structure.

  2011influential reference
• Mephedrone: use, subjective effects and health risks.

  2011cited by this paper
• Seizures and Hyponatremia Related to Ethcathinone and Methylone Poisoning

  2011cited by this paper
• Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones.

  2011influential reference
• Mephedrone (4-methylmethcathinone)-related deaths.

  2011cited by this paper
• Analytical data for identification of the Cannabimimetic Phenylacetylindole JWH-203.

  2011cited by this paper
• [Isomeric analysis of synthetic cannabinoids detected as designer drugs].

  2011cited by this paper
• Designer Drugs / Research Chemicals / Legal Highs - A survey of recent seizures and an attempt to a more effective handling from a Swiss perspective

  2011cited by this paper
• Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.

  2011cited by this paper
• Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs.

  2011cited by this paper
• Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues

  2011cited by this paper
• An analysis of legal highs: do they contain what it says on the tin?

  2011cited by this paper
• Acute poisoning involving the pyrrolidinophenone-type designer drug 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP).

  2011cited by this paper
• Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures.

  2011cited by this paper
• Clinical toxicology of newer recreational drugs

  2011cited by this paper
• Urine Analysis of 3,4-Methylenedioxypyrovalerone in Opioid-Dependent Patients by Gas Chromatography–Mass Spectrometry

  2011cited by this paper
• Acute psychotic sequelae of "bath salts".

  2011cited by this paper
• The adverse consequences of mephedrone use: a case series

  2011cited by this paper
• Methylone and Monoamine Transporters: Correlation with Toxicity

  2011cited by this paper
• Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4-methylmethcathinone) control appears to be effective using this model

  2011cited by this paper
• Survey of current trends in the abuse of psychotropic substances and plants in Japan.

  2011influential reference
• Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service

  2010cited by this paper
• Analyses of second-generation 'legal highs' in the UK: initial findings.

  2010cited by this paper
• Case series of individuals with analytically confirmed acute mephedrone toxicity

  2010cited by this paper
• Drug harms in the UK: a multicriteria decision analysis.

  2010cited by this paper
• The serotonin syndrome as a result of mephedrone toxicity

  2010cited by this paper
• Purchasing 'legal highs' on the Internet--is there consistency in what you get?

  2010cited by this paper
• Analytical Toxicology of Emerging Drugs of Abuse

  2010cited by this paper
• Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.

  2010cited by this paper
• Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity

  2010cited by this paper
• Khat use and monitoring drug use in Europe: the current situation and issues for the future.

  2010cited by this paper
• Spice drugs as a new trend: mode of action, identification and legislation.

  2010cited by this paper
• Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents

  2010cited by this paper
• Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

  2010cited by this paper
• Association of Khat Chewing With Increased Risk of Stroke and Death in Patients Presenting With Acute Coronary Syndrome

  2010cited by this paper
• The CB(2) cannabinoid receptor regulates human sperm cell motility.

  2010cited by this paper
• Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products.

  2010cited by this paper
• Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin.

  2010cited by this paper
• Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone

  2010cited by this paper
• Dependence and psychosis with 4-methylmethcathinone (mephedrone) use

  2010cited by this paper
• Metabolism of designer drugs of abuse: an updated review.

  2010influential reference
• The endocannabinoid system and psychiatric disorders.

  2010cited by this paper
• Themed issue: cannabinoids.

  2010cited by this paper
• Khat chewing, cardiovascular diseases and other internal medical problems: the current situation and directions for future research.

  2010influential reference
• Mephedrone toxicity in a Scottish emergency department

  2010cited by this paper
• Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.

  2010cited by this paper
• Methaemoglobinaemia due to mephedrone (‘snow’)

  2010cited by this paper
• Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.

  2010cited by this paper
• The Characterization of 3,4-Methylenedioxypyrovalerone (MDPV)

  2010cited by this paper
• Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.

  2010cited by this paper
• Association of khat chewing with increased risk of stroke and death in patients presenting with acute coronary syndrome.

  2010cited by this paper
• Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine.

  2009cited by this paper
• Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome

  2009cited by this paper
• Use of khat and posttraumatic stress disorder as risk factors for psychotic symptoms: a study of Somali combatants.

  2009cited by this paper
• The Neurobiology of Addictive Disorders

  2009cited by this paper
• Mechanism of action of cathinone: the active ingredient of khat (Catha edulis).

  2009cited by this paper
• Fluoromethcathinone, a new substance of abuse.

  2009cited by this paper
• Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure.

  2009cited by this paper
• Role of cannabis and endocannabinoids in the genesis of schizophrenia

  2009cited by this paper

• From Psychoactivity to Antimicrobial Agents: Multifaceted Applications of Synthetic Cathinones and Catha edulis Extracts

  2024cites this paper
• Understanding the Evolving Nature of Novel Psychoactive Substances: Mapping 10 Years of Research

  2023cites this paper
• The Novel Psychoactive Substances Epidemic: a Scientometric Perspective

  2022cites this paper
• Systematic analysis of novel psychoactive substances. I. Development of a compound database and HRMS spectral library

  2018cites this paper
• New psychoactive substances—Synthetic stimulants

  2018cites this paper
• The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.

  2017cites this paper
• Monitoring risk behaviour in adolescent pupils regarding consumption of psychoactive substances.

  2017cites this paper
• Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capability.

  2015cites this paper
• Toxicology and Management of Novel Psychoactive Drugs

  2015cites this paper
• Psychoactive substances use experience and addiction or risk of addiction among by Polish adolescents living in rural and urban areas.

  2014cites this paper
• Emerging drugs of abuse: clinical and legal considerations.

  2014cites this paper
• Comprehensive analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances

  2014cites this paper
• Identifying and managing psychiatric emergencies.

  2014cites this paper
• Polish bibliography of occupational medicine, 2012

  2013cites this paper